OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Effect of Different Corticosteroid Dosing Regimens on Clinical Outcomes in Boys With Duchenne Muscular Dystrophy
Michela Guglieri, Kate Bushby, Michael McDermott, et al.
JAMA (2022) Vol. 327, Iss. 15, pp. 1456-1456
Open Access | Times Cited: 87
Michela Guglieri, Kate Bushby, Michael McDermott, et al.
JAMA (2022) Vol. 327, Iss. 15, pp. 1456-1456
Open Access | Times Cited: 87
Showing 1-25 of 87 citing articles:
Safety and efficacy of givinostat in boys with Duchenne muscular dystrophy (EPIDYS): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
Eugenio Mercuri, Juan J. Vílchez, Odile Boespflug‐Tanguy, et al.
The Lancet Neurology (2024) Vol. 23, Iss. 4, pp. 393-403
Closed Access | Times Cited: 43
Eugenio Mercuri, Juan J. Vílchez, Odile Boespflug‐Tanguy, et al.
The Lancet Neurology (2024) Vol. 23, Iss. 4, pp. 393-403
Closed Access | Times Cited: 43
Efficacy and Safety of Vamorolone Over 48 Weeks in Boys With Duchenne Muscular Dystrophy
Utkarsh J. Dang, Jesse M. Damsker, Michela Guglieri, et al.
Neurology (2024) Vol. 102, Iss. 5
Open Access | Times Cited: 24
Utkarsh J. Dang, Jesse M. Damsker, Michela Guglieri, et al.
Neurology (2024) Vol. 102, Iss. 5
Open Access | Times Cited: 24
CONSORT 2025 explanation and elaboration: updated guideline for reporting randomised trials.
Sally Hopewell, An‐Wen Chan, Gary S. Collins, et al.
PubMed (2025) Vol. 389, pp. e081124-e081124
Closed Access | Times Cited: 4
Sally Hopewell, An‐Wen Chan, Gary S. Collins, et al.
PubMed (2025) Vol. 389, pp. e081124-e081124
Closed Access | Times Cited: 4
Current Status Regarding Immunosuppressive Treatment in Patients after Renal Transplantation
Kamila Szumilas, Aleksandra Wilk, Piotr Wiśniewski, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 12, pp. 10301-10301
Open Access | Times Cited: 40
Kamila Szumilas, Aleksandra Wilk, Piotr Wiśniewski, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 12, pp. 10301-10301
Open Access | Times Cited: 40
Long‐term safety and functional outcomes of delandistrogene moxeparvovec gene therapy in patients with Duchenne muscular dystrophy: A phase 1/2a nonrandomized trial
Jerry R. Mendell, Zarife Sahenk, Kelly J. Lehman, et al.
Muscle & Nerve (2023) Vol. 69, Iss. 1, pp. 93-98
Open Access | Times Cited: 32
Jerry R. Mendell, Zarife Sahenk, Kelly J. Lehman, et al.
Muscle & Nerve (2023) Vol. 69, Iss. 1, pp. 93-98
Open Access | Times Cited: 32
Safety and effectiveness of ataluren in patients with nonsense mutation DMD in the STRIDE Registry compared with the CINRG Duchenne Natural History Study (2015–2022): 2022 interim analysis
Eugenio Mercuri, A. Nascimento Osorio, Francesco Muntoni, et al.
Journal of Neurology (2023) Vol. 270, Iss. 8, pp. 3896-3913
Open Access | Times Cited: 20
Eugenio Mercuri, A. Nascimento Osorio, Francesco Muntoni, et al.
Journal of Neurology (2023) Vol. 270, Iss. 8, pp. 3896-3913
Open Access | Times Cited: 20
Functional abilities, respiratory and cardiac function in a large cohort of adults with Duchenne muscular dystrophy treated with glucocorticoids
Marianela Schiava, Robert Muni Lofra, John Bourke, et al.
European Journal of Neurology (2024) Vol. 31, Iss. 6
Open Access | Times Cited: 8
Marianela Schiava, Robert Muni Lofra, John Bourke, et al.
European Journal of Neurology (2024) Vol. 31, Iss. 6
Open Access | Times Cited: 8
263rd ENMC International Workshop: Focus on female carriers of dystrophinopathy: refining recommendations for prevention, diagnosis, surveillance, and treatment. Hoofddorp, The Netherlands, 13-15 May 2022
Anna Sárközy, Rosaline C. M. Quinlivan, John Bourke, et al.
Neuromuscular Disorders (2023) Vol. 33, Iss. 3, pp. 274-284
Open Access | Times Cited: 16
Anna Sárközy, Rosaline C. M. Quinlivan, John Bourke, et al.
Neuromuscular Disorders (2023) Vol. 33, Iss. 3, pp. 274-284
Open Access | Times Cited: 16
The Role of Mitochondria in Mediation of Skeletal Muscle Repair
Stephen E. Alway, Hector G. Paez, Christopher R. Pitzer
Muscles (2023) Vol. 2, Iss. 2, pp. 119-163
Open Access | Times Cited: 16
Stephen E. Alway, Hector G. Paez, Christopher R. Pitzer
Muscles (2023) Vol. 2, Iss. 2, pp. 119-163
Open Access | Times Cited: 16
Osteoporosis in children and young adults
Sophia Sakka
Best Practice & Research Clinical Rheumatology (2022) Vol. 36, Iss. 3, pp. 101776-101776
Closed Access | Times Cited: 20
Sophia Sakka
Best Practice & Research Clinical Rheumatology (2022) Vol. 36, Iss. 3, pp. 101776-101776
Closed Access | Times Cited: 20
Vamorolone improves Becker muscular dystrophy and increases dystrophin protein in bmx model mice
Nikki M. McCormack, Nhu Nguyen, Christopher B. Tully, et al.
iScience (2023) Vol. 26, Iss. 7, pp. 107161-107161
Open Access | Times Cited: 11
Nikki M. McCormack, Nhu Nguyen, Christopher B. Tully, et al.
iScience (2023) Vol. 26, Iss. 7, pp. 107161-107161
Open Access | Times Cited: 11
274th ENMC international workshop: Recommendations for optimizing bone strength in neuromuscular disorders. Hoofddorp, The Netherlands, 19–21 January 2024
Nicol C. Voermans, Anne T. M. Dittrich, Sara Liguori, et al.
Neuromuscular Disorders (2024) Vol. 43, pp. 1-13
Closed Access | Times Cited: 4
Nicol C. Voermans, Anne T. M. Dittrich, Sara Liguori, et al.
Neuromuscular Disorders (2024) Vol. 43, pp. 1-13
Closed Access | Times Cited: 4
Cardiac therapies for Duchenne muscular dystrophy
Md Nur Ahad Shah, Toshifumi Yokota
Therapeutic Advances in Neurological Disorders (2023) Vol. 16
Open Access | Times Cited: 10
Md Nur Ahad Shah, Toshifumi Yokota
Therapeutic Advances in Neurological Disorders (2023) Vol. 16
Open Access | Times Cited: 10
Targeting EP2 Receptor Improves Muscle and Bone Health in Dystrophin−/−/Utrophin−/− Double-Knockout Mice
Xueqin Gao, Yan Cui, Greg Zhang, et al.
Cells (2025) Vol. 14, Iss. 2, pp. 116-116
Open Access
Xueqin Gao, Yan Cui, Greg Zhang, et al.
Cells (2025) Vol. 14, Iss. 2, pp. 116-116
Open Access
A Parent Project Muscular Dystrophy-sponsored International Workshop Report on Endocrine and Bone Issues in Patients with Duchenne Muscular Dystrophy: An Ever-changing Landscape
Leanne M. Ward, David R. Weber, Sze Choong Wong, et al.
Journal of Neuromuscular Diseases (2025) Vol. 12, Iss. 1
Closed Access
Leanne M. Ward, David R. Weber, Sze Choong Wong, et al.
Journal of Neuromuscular Diseases (2025) Vol. 12, Iss. 1
Closed Access
Observational study of changes to glucocorticosteroid prescribing patterns in duchenne muscular dystrophy in the UK over the last decade
Gregory Landon, Georgia Stimpson, Michela Guglieri, et al.
Journal of Neurology Neurosurgery & Psychiatry (2025), pp. jnnp-335223
Closed Access
Gregory Landon, Georgia Stimpson, Michela Guglieri, et al.
Journal of Neurology Neurosurgery & Psychiatry (2025), pp. jnnp-335223
Closed Access
Stress exposure in the mdx mouse model of Duchenne muscular dystrophy provokes a widespread metabolic response
Erynn E. Johnson, James M. Ervasti
FEBS Journal (2025)
Open Access
Erynn E. Johnson, James M. Ervasti
FEBS Journal (2025)
Open Access
Comparing intermittent and daily prednisone in duchenne muscular dystrophy: a systematic review and meta-analysis
Eeshal Zulfiqar, Sonia Hurjkaliani, Shahood Ahmed Umar, et al.
Annals of Medicine and Surgery (2025) Vol. 87, Iss. 3, pp. 1637-1645
Open Access
Eeshal Zulfiqar, Sonia Hurjkaliani, Shahood Ahmed Umar, et al.
Annals of Medicine and Surgery (2025) Vol. 87, Iss. 3, pp. 1637-1645
Open Access
A historical perspective on the development of antisense oligonucleotide treatments for Duchenne muscular dystrophy and spinal muscular atrophy
Annemieke Aartsma‐Rus, Shin’ichi Takeda
Journal of Neuromuscular Diseases (2025)
Closed Access
Annemieke Aartsma‐Rus, Shin’ichi Takeda
Journal of Neuromuscular Diseases (2025)
Closed Access
Inhibiting EZH2 complements steroid effects in Duchenne muscular dystrophy
Eun Young Jeon, Yejin Kwak, Hyeji Kang, et al.
Science Advances (2025) Vol. 11, Iss. 11
Open Access
Eun Young Jeon, Yejin Kwak, Hyeji Kang, et al.
Science Advances (2025) Vol. 11, Iss. 11
Open Access
A Hypothesized Therapeutic Role of (Z)-Endoxifen in Duchenne Muscular Dystrophy (DMD)
H. Lawrence Remmel, Sandra S. Hammer, L. Neff, et al.
Degenerative Neurological and Neuromuscular Disease (2025) Vol. Volume 15, pp. 1-15
Open Access
H. Lawrence Remmel, Sandra S. Hammer, L. Neff, et al.
Degenerative Neurological and Neuromuscular Disease (2025) Vol. Volume 15, pp. 1-15
Open Access
Multiple Comparisons Procedures for Analyses of Joint Primary Endpoints and Secondary Endpoints
Xiaolong Luo, Lerong Li, Oleksandr Savenkov, et al.
Pharmaceutical Statistics (2025) Vol. 24, Iss. 3
Closed Access
Xiaolong Luo, Lerong Li, Oleksandr Savenkov, et al.
Pharmaceutical Statistics (2025) Vol. 24, Iss. 3
Closed Access
Update on Treatment of Dystrophinopathy
Dennis Keselman, John F. Brandsema
Current Treatment Options in Neurology (2025) Vol. 27, Iss. 1
Open Access
Dennis Keselman, John F. Brandsema
Current Treatment Options in Neurology (2025) Vol. 27, Iss. 1
Open Access
Uso de glucocorticoides en pacientes con distrofia muscular de Duchenne
Edna Julieth Bobadilla-Quesada, Juan David Lasprilla Tovar, Norma Carolina Barajas Viracachá, et al.
Revista Ciencias de la Salud (2025) Vol. 23, Iss. Especial, pp. 1-19
Open Access
Edna Julieth Bobadilla-Quesada, Juan David Lasprilla Tovar, Norma Carolina Barajas Viracachá, et al.
Revista Ciencias de la Salud (2025) Vol. 23, Iss. Especial, pp. 1-19
Open Access
